Khosla Ventures related stories
All articles and analysis
Food quality tester Clear Labs raises $21 mlnMenlo Park, California-based Clear Labs, provider of a platform for food safety testing, announced it has raised $21 million in funding. The Series B2 round was led by Menlo Ventures, with participation from Wing VC, Dentsu Ventures, Felicis Ventures and Khosla Ventures, along with a number of food production companies. The company, founded in 2014, has now raised $45 million in total funding.
- VC-backed Guardant Health goes public
Redwood City, California-based Guardant Health, a liquid biopsy company, has raised $237.5 million for its IPO after pricing its 12.5 million shares at $19 per share. The stock began trading October 4, 2018 on the NASDAQ under the ticker symbol "GH." J.P. Morgan Securities LLC and BofA Merrill Lynch are the lead underwriters. Guardant Health's pre-IPO backers included SoftBank Vision Fund, Sequoia Capital, Khosla Ventures and Lightspeed Venture Partners.
- Pymetrics grabs $40 mln Series B
Pymetrics, which develops predictive hiring and career assessment technology, has raised $40 million in Series B funding. General Atlantic led the round with participation from other investors that included Salesforce Ventures, Workday Ventures, Khosla Ventures and Jazz Venture Partners.
- Grubhub agrees to buy VC-backed Tapingo for $150 mln
Grubhub has agreed to acquire Israeli-based Tapingo, provider of an on-campus food ordering platform, for $150 million. The deal is expected to close in the fourth quarter. Tapingo, which also has an office in San Francisco, has raised about $36 million in venture funding from Khosla Ventures, Qualcomm Ventures, Viola Ventures and DCM Ventures, among others.
- GitLab raises $100 mln, led by Iconiq, surpasses $1 bln in valuation
San Francisco-based GitLab, provider of an open core collaboration platform for developers, announced it has raised a $100 million Series D round of funding valuing the company at $1.1 billion. The funding round was led by Iconiq Capital, the Silicon Valley fund that is an investment vehicle for the founders of Facebook, LinkedIn and Twitter. The company, which has now raised more than $145 million since it was founded, is eyeing an IPO in 2020.
- Khosla Ventures backs Scipher Medicine
Waltham, Massachusetts-based Scipher Medicine, a developer of a molecular technology platform that can predict if a patient will actually respond to a particular drug therapy has closed its latest funding, raising a total tally of $10 million. Khosla Ventures led the latest round.
- Nebula Genomics inks $4.3 mln seed
San Francisco and Boston-based Nebula Genomics, a human genome sequencing and health big data company, has secured $4.3 million in seed funding. The investors included Khosla Ventures, Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, Great Point Ventures, Windham Venture Partners, Hemi Ventures, Mirae Asset, Hikma Ventures and Heartbeat Labs.